MedTrace Logo

Pre-Operative Ketamine Infusion for Post Operative Pain Control After Revision Spinal Surgery

NCT06066879 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-10-04

No results posted yet for this study

Summary

To determine if a pre-operative ketamine infusion would provide a similar decrease in post-operative analgesic and opioid consumption as intra-operative ketamine, but expand the monitoring period through the post-operative phase up to 90 days. Hypothesis is that pre-operative ketamine infusion will lead to a decrease in narcotic consumption from baseline following an elective cervical or lumbar fusion, leading to increased functionality and quality of life for these patients.

Conditions

  • Revision Spine Surgery
  • Fusion of Spine
  • Cervical Fusion
  • Lumbar Fusion

Interventions

DRUG

Ketamine Hydrochloride

Pre-Operative Ketamine infusion

Sponsors & Collaborators

  • IDAHO PANHANDLE HEALTH DISTRICT

    collaborator UNKNOWN

  • AXIS Spine Center- a division of Northwest Specialty Hospital

    lead OTHER

Principal Investigators

  • Jessica Jameson, MD · division of NSWH

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-18
Primary Completion
2024-09-30
Completion
2024-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06066879 on ClinicalTrials.gov